Cerner (NASDAQ:CERN) had its price objective upped by research analysts at Wells Fargo & Co from $72.00 to $80.00 in a research note issued on Thursday, The Fly reports. The firm presently has an “outperform” rating on the stock. Wells Fargo & Co‘s target price suggests a potential upside of 9.42% from the stock’s previous close.
A number of other equities research analysts have also recently weighed in on CERN. Barclays lifted their price target on Worldpay from $131.00 to $136.00 and gave the company an “overweight” rating in a report on Wednesday, April 10th. Citigroup lifted their price target on Facebook from $212.00 to $240.00 and gave the company a “buy” rating in a report on Thursday. BidaskClub cut Retrophin from a “hold” rating to a “sell” rating in a report on Thursday. Canaccord Genuity lifted their price target on Marathon Gold from C$1.80 to C$2.00 in a report on Thursday. Finally, Cantor Fitzgerald lifted their price target on Cerner from $75.00 to $85.00 and gave the company an “overweight” rating in a report on Monday, July 8th. Two analysts have rated the stock with a sell rating, three have issued a hold rating and eleven have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $72.43.
Shares of CERN traded up $0.19 during mid-day trading on Thursday, reaching $73.11. 2,586,266 shares of the company’s stock traded hands, compared to its average volume of 2,158,632. The firm’s 50-day simple moving average is $73.23. The company has a market cap of $23.56 billion, a PE ratio of 33.08, a P/E/G ratio of 2.06 and a beta of 0.89. The company has a quick ratio of 2.55, a current ratio of 2.58 and a debt-to-equity ratio of 0.09. Cerner has a 12 month low of $48.78 and a 12 month high of $76.47.
Cerner (NASDAQ:CERN) last released its quarterly earnings results on Wednesday, July 24th. The company reported $0.60 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.58 by $0.02. The company had revenue of $1.43 billion for the quarter, compared to analysts’ expectations of $1.44 billion. Cerner had a return on equity of 14.90% and a net margin of 10.75%. The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.62 earnings per share. As a group, analysts expect that Cerner will post 2.44 EPS for the current fiscal year.
In other Cerner news, Director R Halsey Wise purchased 7,600 shares of the firm’s stock in a transaction on Tuesday, April 30th. The shares were purchased at an average price of $65.76 per share, for a total transaction of $499,776.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director John J. Greisch purchased 9,000 shares of the firm’s stock in a transaction on Thursday, May 2nd. The stock was acquired at an average price of $67.57 per share, for a total transaction of $608,130.00. The disclosure for this purchase can be found here. In the last three months, insiders have sold 441,468 shares of company stock worth $30,777,997. 4.71% of the stock is owned by corporate insiders.
A number of institutional investors have recently bought and sold shares of CERN. Nelson Roberts Investment Advisors LLC acquired a new position in Cerner in the first quarter worth approximately $25,000. Moody National Bank Trust Division grew its position in Cerner by 72.5% in the first quarter. Moody National Bank Trust Division now owns 483 shares of the company’s stock worth $28,000 after buying an additional 203 shares during the last quarter. Advisory Alpha LLC acquired a new position in Cerner in the first quarter worth approximately $28,000. Creative Financial Designs Inc. ADV grew its position in Cerner by 303.4% in the first quarter. Creative Financial Designs Inc. ADV now owns 710 shares of the company’s stock worth $41,000 after buying an additional 534 shares during the last quarter. Finally, Valeo Financial Advisors LLC acquired a new position in Cerner in the second quarter worth approximately $49,000. Hedge funds and other institutional investors own 81.51% of the company’s stock.
Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.
Read More: Intrinsic Value
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.